Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-08

Clinical Trial Update: Fluoxetine for Anxious Children [Phase 3]

View source ↗

Summary

Phase 3 study of fluoxetine in children with anxiety disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prozac (Fluoxetine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Anxiety Disorders | Phase 3 | Status: COMPLETED